A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules
Clinical trial NCT03758469 · COMPLETED
Trial details
- NCT number
- NCT03758469
- Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2019-01-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.